UCSD Faculty
Grace M. Kuo, Pharm.D., M.P.H (Principal
Investigator, Program Director)
http://pharmacy.ucsd.edu/faculty/Kuo.shtml
is an Associate Professor of Clinical Pharmacy and Associate
Adjunct Professor of Family and Preventive Medicine. She is the
Director of San Diego Pharmacist Resource and Research Network, and
the Director for the American College of Clinical Pharmacy
Practice-Based Research Network. Dr. Kuo has over 10 years of
clinical experience working at different healthcare settings
(hospital, primary care clinic, home care and community pharmacy,
and consulting). She is currently an AHRQ-funded career development
award recipient and a health services researcher, with ongoing
projects titled "Safe Use of Medications in Primary Care
Practices". She has conducted several medication safety research
studies funded by the Agency for Healthcare Research and Quality
and the National Institutes of Health. She has also collaborated
with primary care physicians from the American Academy of Family
Physicians and consortium of practice-based research networks on
national studies related to medication error reports. She is
responsible for the overall management of the program and oversees
the development, dissemination, and evaluation of the education
program.
Kelly Lee, Pharm.D., BCPP (Co-Investigator, Program
Associate)
http://pharmacy.ucsd.edu/faculty/lee.shtml
is an Assistant Professor of Clinical Pharmacy. Dr. Lee is board
certified in psychiatric pharmacy ; she manages a Depression
Management Primary Care Clinic. She has experience teaching
psychiatric and neurologic disorders to psychiatry residents,
medical students, pharmacy students and nurses. Dr. Lee has
extensive experience in planning CE programs for pharmacists . She
has served as the Meeting Program Associate for ASHP and has
coordinated educational symposia at the Midyear Clinical Meetings
(attendance of over 20,000 pharmacists). She has served on the
program committee for the College of Psychiatric and Neurologic
Pharmacists and is currently the Chair of the 2009 Program
Committee. As Chair, she leads a group of 12 committee members to
organize and recruit key thought leaders in psychiatry and
neurology for the four-day national meeting. Dr. Lee is currently
collaborating with Dr. John R. Kelsoe to investigate genetic
variants that are responsible for valproic acid response in
patients with bipolar disorder. Dr. Lee will be involved in all
aspects of the educational campaign including curriculum
development, dissemination efforts, and program evaluation. She
will serve as a presenter for specific components of the education
program to pharmacists, physicians, and students.
Joseph D. Ma, Pharm.D. (Co-Investigator, Program
Associate)
http://pharmacy.ucsd.edu/faculty/Ma.shtml
is an Assistant Professor of Clinical Pharmacy. He shares a dual
appointment with the Moores UCSD Cancer Center. Dr. Ma has
evaluated the influence of genetic factors, specifically the
pharmacogenetics of the cytochrome p-450 enzymes, on inter- and
intraindividual pharmacokinetic variability of drugs. Dr. Ma has
served as co-coordinator for a Therapeutics course, which
integrates knowledge of anatomy , physiology, pathophysiology,
pharmaceutics, pharmacokinetics, and pharmacology in learning how
to make appropriate therapeutic decisions. At the Moores Cancer
Center - Clinical Trials Office, Dr. Ma examines confounding
factors, such as age, disease status, drug-metabolizing enzyme
function, and a patient's genotype in accounting for a patient's
response to chemotherapy agents. Dr. Ma will be involved in all
aspects of the educational campaign including curriculum
development, dissemination, and program evaluation. He will serve
as a presenter for the education program to pharmacists,
physicians, and students.
Philip E. Bourne, Ph.D. (Co-Investigator, SciVee™
Co-Founder)
http://pharmacy.ucsd.edu/faculty/bourne.shtml
is a Professor in the Department of Pharmacology, Co-director of
the Protein Data Bank and an Adjunct Professor at the Burnham
Institute and the Keck Graduate Institute. He serves on the
advisory board of PharmGKB and is an elected fellow of the American
Medical Informatics Association. He is the Founding Editor-in-Chief
of the open access journal PLoS Computational Biology, and a long
standing member of the National Science Foundation and National
Institutes of Health panels. Dr. Bourne's interests focus on
bioinformatics and structural bioinformatics. He has published over
200 papers and 4 books, one of which sold over 120,000 copies. He
has co-founded 4 companies, including SciVee. Dr. Bourne is
committed to improving better integration and dissemination of data
and results. Dr. Bourne will assist in online hosting of the
education program, video production, and information technology
(IT) platform configurations.
Theodore Ganiats, M.D. (Co-Investigator, Physician
Liaison)
http://hsrcreports.ucsd.edu/ExpertSearch/ViewExpert.aspx?IDExpert=1
is Professor and interim chair of the Department of Family and
Preventive Medicine and the Executive Director of the UCSD Health
Services Research Center. Dr. Ganiats' work on cost-effectiveness
analysis includes prospective data as well as data from literature
reviews. Due to his interest in clinical policy and evidence-based
medicine, Dr. Ganiats has participated as a member or chair on over
30 national guideline panels and quality improvement initiatives
spanning multiple disciplines. In addition, he is a member of the
California Health Benefit Review Program, where the University of
California creates rapid turn-around assessments of health benefit
mandate bills for the California legislature. Dr. Ganiats will help
disseminate the education program to primary care physicians and
students. He will evaluate the content of the module-based
education program as it relates to the clinical application of
pharmacogenomics.
James Halpert, Ph.D. (Co-Investigator, Content
Expert)
http://pharmacy.ucsd.edu/faculty/Halpert.shtml
is Professor and Associate Dean for Scientific Affairs. He was a
member of the NIH Pharmacology Study Section and served as the
Chairman for 2 years. He was Editor for Drug Metabolism and
Disposition from 2000-2005. He has authored 160 peer-reviewed
publications, is the prior recipient of an NIH Career Development
Award, and currently holds a MERIT Award. Dr. Halpert's research
focuses on the structure and function of CYP2B and 3A subfamilies.
Dr. Halpert's work on the CYP3A subfamily has focused on
determining the basis of species and individual differences in drug
metabolism. His role will involve the curriculum development of the
education program with an emphasis on CYP pharmacogenomics. He will
critique the content of the module-based educational program as it
relates to CYP pharmacogenetics and pharmacogenomics.
Palmer Taylor, Ph.D. (Co-Investigator, Content
Expert and Institutional Support)
http://pharmacy.ucsd.edu/faculty/taylor.shtml
is the founding Dean of SSPPS, Sandra and Monroe Trout Professor
of Pharmacology, and Associate Vice Chancellor of Health Sciences.
Dr. Taylor's group cloned the first acetylcholinesterase (AChE)
gene, and this was followed by analysis of its genomic DNA to
delineate regulatory regions, the multiple splicing options and
gene expression profiles in nerve and muscle. His research team has
examined SNP's and INDEL's in target proteins in the cholinergic
nervous system and related them to autonomic nervous system
phenotypes. As a pharmacologist engaged in the training of medical
and pharmacy students for over three decades and a frequent author
and editor of textbooks, such as "Goodman & Gilman's
Pharmacological Basis of Therapeutics," Dr. Taylor and faculty at
UCSD established a pharmacogenomics course four years ago for
Pharm.D., M.D., and Ph.D. students at UCSD. He will support the
faculty members' endeavors to develop the education program and
evaluate the content of the education program.